Clinical Trial: ALLIANCE A071701

ALLIANCE A071701

Status: Open

Genomically-Guided Treatment Trial in Brain Metastases

A071701-MRTX849 (adagrasib) (KRAS G12C) Cohort is closed to accrual of new patients (Step 1),  effective Friday, April 4, 2025

 A071701-Eentrectinib (NTRK/ROS1) Cohort is closed to accrual of new patients (Step 1) effective January 9, 2024.